Publicacións en colaboración con investigadores/as de Hospital de Sant Pau i Santa Tecla (14)

2022

  1. Prediction of peritoneal soiling in acute appendicitis with simple clinical and laboratory data. Prospective, multicenter, cohort study of 2,645 adult patients nationwide

    International Journal of Surgery, Vol. 104

  2. Simplified risk-prediction for benchmarking and quality improvement in emergency general surgery. Prospective, multicenter, observational cohort study

    International Journal of Surgery, Vol. 97

2018

  1. Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study

    Contact Dermatitis, Vol. 78, Núm. 1, pp. 76-82

2016

  1. An assessment of the management of spasticity in Spain: The 5E study

    Revista de Neurologia, Vol. 63, Núm. 7, pp. 289-296

2012

  1. Mortality after surgery in Europe: A 7 day cohort study

    The Lancet, Vol. 380, Núm. 9847, pp. 1059-1065

2011

  1. Case-control study for colorectal cancer genetic susceptibility in EPICOLON: Previously identified variants and mucins

    BMC Cancer, Vol. 11

  2. Clinical utility of maraviroc

    Clinical Drug Investigation, Vol. 31, Núm. 8, pp. 527-542

2010

  1. El papel de las combinaciones de antirretrovirales a dosis fijas en el tratamiento de la infeccin por VIH-1

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 9, pp. 615-620

2009

  1. The changing face of HIV/AIDS in treated patients

    Current HIV Research, Vol. 7, Núm. 4, pp. 365-377

2008

  1. Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903

    Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092

  2. Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients

    Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 1, pp. 206-209

  3. Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: A multicentre pilot study

    HIV Medicine, Vol. 9, Núm. 7, pp. 508-513

2007

  1. Cost minimization analysis of the different combinations of nucleoside analog reverse transcriptase inhibitors associated with adverse events in HIV-1 infected patients

    Pharmacoeconomics - Spanish Research Articles, Vol. 4, Núm. 1, pp. 25-36

2006

  1. Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir

    AIDS, Vol. 20, Núm. 10, pp. 1407-1414